JUUL LABS, INC. v. 4X PODS

District Court, D. New Jersey·Decided April 28, 2020·No. 2:18-cv-15444·Unknown

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY ____________________________________ : JUUL LABS, INC., : Civil Action No. 18-15444 (KM) (MAH) : Plaintiff, : : v. : OPINION : 4X PODS, et al., : : Defendants. : ____________________________________:

I. INTRODUCTION This matter comes before the Court on Juul Labs, Inc.’s (“JLI”) Motion for Leave to File an Amended Complaint. D.E. 108. Pursuant to Federal Rule of Civil Procedure 78 and Local Civil Rule 78.1, the Court decides this motion without oral argument. For the reasons set forth below, the Court will grant JLI’s motion. II. BACKGROUND1 Plaintiff brings claims for violations of the Lanham Act, copyright infringement, and NJ common law. Plaintiff manufactures electronic nicotine delivery systems (“ENDS”). Complaint, Oct. 30, 2018, D.E. 1, ¶ 2. The ENDS use two components: “(1) a device and (ii) disposable pods (“JUUL pods”) prefilled with a proprietary mixture of vaporizer carriers, nicotine salt extracts, and flavoring (together, “e-liquid”).” Id., ¶ 3. A user would insert the pod into the device and then use the mouthpiece to inhale. Id. That causes the e-liquid in the pod to heat up and allows the

1 Because the Court writes for the parties, the Court briefly summarizes the pertinent facts. The Court also assumes as true the factual allegations in the complaint for the purpose of this motion. See Batoff v. State Farm Ins. Co., 977 F.2d 848, 851-52 (3d Cir. 1992). user to inhale the vaporized e-liquid. Id. JLI has federally registered trademarks for its refill pods, id., ¶ 22, and copyrights for the visual works depicted on JLI packaging. Id., ¶ 35. JLI alleges that Defendants manufacture and sell a product known as “4X PODS,” and that “[t]he 4X PODS product, on its face, copies virtually all components of the JUUL Pod Logo

Trademark, JUUL Packaging Trade Dress, and Copyrighted Works.” Id., ¶¶ 40-43. JLI further alleges that “the 4X PODS brand packaging prominently bears the JUUL trademark, and slavishly copies virtually all elements of the JUUL Packaging Trade Dress, which strongly indicates Defendants' intent to copy, and necessary knowledge of, JLI's trademarks and trade dress.” Id., ¶ 45. According to JLI, Defendant Gregory Grishayev organized and directed the alleged infringing conduct, and Defendant Electric Tobacconist has engaged in the distribution and sale of 4X PODS products. Id., ¶¶ 48-49. In terms of damages, the Complaint alleges that the alleged infringement has caused confusion in the marketplace. Id., ¶ 42 & n.8-9, ¶¶ 54-55. JLI now moves for leave to file an Amended Complaint to: (1) name Eonsmoke, LLC, doing business as 4X PODS, as the corporate Defendant; (2) name Michael J. Tolmach as a

Defendant; (3) add an additional claim against Mr. Tolmach to hold him individually liable for the alleged infringement of JLI’s copyrights, trade dress and trademarks; (4) add a claim for infringement of JLI’s JUUL Wordmark, Registration No. 4818664; (5) plead that if it prevails on its claims against Defendants, the Court in awarding relief should pierce the corporate veil of Eonsmoke and hold Defendants Grishayev and Tolmach personally liable; and (6) plead additional facts showing the harm to Plaintiff and its reputation. Defendants argue that the Court should deny JLI’s motion to amend because the amendment is the result of undue delay and bad faith, it is futile, and granting the motion would prejudice Defendants. III. ANALYSIS The first issue for the Court is whether Federal Rule of Civil Procedure 15 or 16 governs Plaintiff’s motion to amend. Karlo v. Pittsburgh Glass Works, LLC, Civ. No. 10-1283, 2011 WL 5170445, at *2 (W.D. Pa. Oct. 31, 2011). Rule 15 states, in pertinent part, “a party may amend its

pleading only with the opposing party’s written consent or the court’s leave. The court should freely give leave when justice so requires.” Fed. R. Civ. P. 15(a)(2). “Rule 16, on the other hand, requires a party to demonstrate ‘good cause’ prior to the Court amending its scheduling order.” Karlo, 2011 WL 5170445, at *2 (citing Fed. R. Civ. P. 16(b)(4)). There is a recognized tension between Rule 15 and Rule 16 that has not been directly resolved by the United States Court of Appeals for the Third Circuit. See Race Tires America, Inc. v. Hoosier Racing Tire Corp., 614 F.3d 57, 84 (3d. Cir. 2010); Graham v. Progressive Direct Ins. Co., 271 F.R.D. 112, 118 (W.D. Pa. 2010). However, courts “within the Third Circuit have consistently reached the same conclusion: a party seeking to amend the pleadings after the deadline set by the Court must satisfy the requirements of Rule 16(b)(4)—i.e., they must show

‘good cause.’” Karlo, 2011 WL 5170445, at *2 (citing Fed. R. Civ. P. 16(b)(4)) (emphasis added). Here, JLI initially sought leave by letter application to file the proposed amended pleading on October 31, 2019, before the deadline set by this Court for doing so, i.e., November 15, 2019. Defendants filed a letter objecting to the proposed amendment on November 1, 2019. Therefore, on November 4, 2019, the Court directed Plaintiff to file a formal motion to amend on or before December 6, 2019. Plaintiff filed the instant motion on December 4, 2019. Based on these facts in the record, the Court finds that Plaintiff’s request to amend its pleading was made before the deadline for doing so. Accordingly, the Court need not consider Rule 16, and instead, will turn to Rule 15 to determine whether to permit JLI to file its amended pleading. Under Rule 15 of the Federal Rules of Civil Procedure, a plaintiff may amend his or her complaint once as of right, and “courts may grant subsequent amendments ‘when justice so requires.’” Fraser v. Nationwide Mut. Ins. Co., 352 F.3d 107, 116 (3d Cir. 2003) (quoting Fed. R. Civ. P. 15(a)). Further, “leave to amend should be freely given when justice so requires, including

for a curative amendment unless such an amendment would be inequitable or futile.” Free Speech Coalition, Inc. v. Att’y Gen. of U.S., 677 F.3d 519, 545 (3d Cir. 2012). The Court may deny leave to amend the pleadings only when there is (1) undue delay, (2) bad faith or dilatory motive, (3) undue prejudice, (4) repeated failures to cure deficiencies, or (5) futility of amendment. Foman v. Davis, 371 U.S. 178, 182 (1962); Long v. Wilson, 393 F.3d 390, 400 (3d Cir. 2004). Defendants argue that JLI has unduly delayed in seeking to amend its pleading. Br. in Opp., Dec. 23, 2019, D.E. 134, at 3-4.

Free access — add to your briefcase to read the full text and ask questions with AI

JUUL LABS, INC. v. 4X PODS, (D.N.J. 2020).

JUUL LABS, INC. v. 4X PODS (JUUL LABS, INC. v. 4X PODS) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
West Penn Allegheny Health System, Inc. v. UPMC
627 F.3d 85 (Third Circuit, 2010)
Curtis Long v. Harry Wilson, Superintendent
393 F.3d 390 (Third Circuit, 2004)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Fraser v. Nationwide Mutual Insurance
352 F.3d 107 (Third Circuit, 2003)
Lorenz v. CSX Corp.
1 F.3d 1406 (Third Circuit, 1993)
Linus Holding Corp. v. Mark Line Indus., LLC
376 F. Supp. 3d 417 (D. New Jersey, 2019)
Graham v. Progressive Direct Insurance
271 F.R.D. 112 (W.D. Pennsylvania, 2010)
Adams v. Gould Inc.
739 F.2d 858 (Third Circuit, 1984)